HIV Diagnostics Test Market Size Accelerated by Growing Adoption of At-Home Testing Kits

HIV diagnostics tests play a key role in controlling the spread of HIV/AIDS by identifying individuals infected with the virus. Growing adoption of at-home HIV testing kits has enabled widespread confidential testing. At-home HIV testing kits offer privacy, enable self-testing, and provide rapid test results within 15-30 minutes. Growing awareness about HIV/AIDS and initiatives by governments and non-profit organizations to promote testing is driving the adoption of at-home HIV testing kits. The global HIV Diagnostics Test Market is estimated to be valued at US$ 4,263.62 million in 2023 and is expected to exhibit a CAGR of 9.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Growing awareness through informative campaigns on social media platforms has
accelerated the adoption of at-home HIV testing kits. Various national and
international organizations are promoting awareness about HIV testing through
innovative social media campaigns. Facebook, Instagram and Twitter are being
leveraged for HIV/AIDS awareness activities such as sharing information about
HIV preventions, effects of the disease, location of testing facilities etc.
Social media campaigns are empowering people to take control of their sexual
health by enabling confidential self-testing through at-home HIV testing kits.
Rising internet and smartphone penetration especially in developing countries
is supporting the scale of social media based HIV awareness initiatives, thus
driving the adoption of at-home HIV testing kits.
The global HIV Diagnostics Test market is segmented into tests, end-user, and region. Based on tests, the market can be categorized into antibody tests, viral load tests, CD4 count tests, test for early infant diagnosis, and screening tests. Antibody tests dominate the market as it is widely used for screening and diagnosing HIV/AIDS infection. These tests detect antibodies produced by the body's immune system in response to HIV. Based on end-user, the market is fragmented into diagnostic laboratories, hospitals, blood banks, home care setting, and others. Diagnostic laboratories hold the maximum share as these facilities are the primary locations where people go for HIV testing.
Key Takeaways
The global HIV Diagnostics Test market is expected to witness high growth. The market size is projected to reach US$ 4,263.62 million by 2024, growing at a CAGR of 9.0% during 2023-2030 forecast period.
Regional analysis: North America dominates the market currently due to rising prevalence of HIV infections, availability of advanced treatment facilities, and favorable reimbursement policies in the region. However, Asia Pacific is expected to grow at the fastest pace during the forecast period owing to increasing awareness regarding prevention and treatment of HIV, growing healthcare infrastructure, and rising per capita healthcare expenditure in developing Asian countries.
Key players: Key players operating in the HIV Diagnostics Test market are Abbott, Bio-Rad Laboratories, Inc., Hologic, Inc., Siemens Healthineers, Roche AG, Beckman Coulter Inc., OraSure Technologies, Inc., Becton, Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems, Inc., Zyomyx Incorporation, Bristol –Myers Squibb, Janssen Pharmaceutica NV, QIAGEN N.V., and ViiV Healthcare Ltd. These players are focusing on new product launches, strategic collaborations, and geographical expansions to gain market share.
Comments
Post a Comment